Oncometabolic Nuclear Reprogramming of Cancer Stemness

Area of Science:

• Metabolic regulation of epigenetics
• Cancer stem cell biology
• Cellular reprogramming

Background:

• Oncometabolites can induce a reprogramming-prone cellular state.
• Cellular reprogramming is key to generating induced pluripotent stem cells.
• Understanding cancer stem cell generation is crucial for oncology.

Purpose of the Study:

• To investigate the role of oncometabolites in pathological nuclear reprogramming.
• To elucidate the metabolo-epigenetic mechanisms driving cancer stem cell formation.
• To model the impact of oncometabolites on cell differentiation and stemness.

Main Methods:

• Systems biology approach integrating mathematical modeling and computation.
• Proof-of-concept studies using live cell experiments.
• Biomathematical modeling of nucleosome modification and epigenetic regulation.

Main Results:

• Oncometabolites accelerate and enhance the dedifferentiation of epithelial cells into stem-like states.
• The biomathematical model demonstrates oncometabolites lower energy barriers between cell states.
• Oncometabolites reduce reprogramming time and increase the stem cell attractor basin size.

Conclusions:

• Oncometabolic nuclear reprogramming is a novel metabolo-epigenetic mechanism.
• This process contributes to the generation of cancer stem-like cells.
• Findings provide insights into cancer development and potential therapeutic targets.